Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2011-09-30 | 2011-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues | ||||||||||||||||
net premiums | 4,280,000,000 | 4,151,000,000 | 4,019,000,000 | 4,156,000,000 | 4,391,000,000 | 3,920,000,000 | 5,376,000,000 | 4,108,000,000 | 4,255,000,000 | 3,337,000,000 | 3,385,000,000 | 3,446,000,000 | 3,247,000,000 | 3,230,000,000 | 1,776,165,000 | 1,788,676,000 |
net investment income | 1,475,000,000 | 1,408,000,000 | 1,232,000,000 | 1,185,000,000 | 1,188,000,000 | 1,082,000,000 | 961,000,000 | 956,000,000 | 922,000,000 | 857,000,000 | 856,000,000 | 828,000,000 | 769,000,000 | 754,000,000 | ||
investment related gains | 13,000,000 | -44,000,000 | -79,000,000 | -247,000,000 | -78,000,000 | -271,000,000 | -149,000,000 | -155,000,000 | -126,000,000 | -123,000,000 | -77,000,000 | 8,000,000 | -134,000,000 | -254,000,000 | -11,408 | -151,008 |
other revenues | 436,000,000 | 84,000,000 | 88,000,000 | 147,000,000 | 150,000,000 | 147,000,000 | 149,000,000 | 98,000,000 | 102,000,000 | 85,000,000 | 87,000,000 | 93,000,000 | 184,000,000 | 157,000,000 | 90,132,000 | 50,477,000 |
total revenues | 6,204,000,000 | 5,599,000,000 | 5,260,000,000 | 5,241,000,000 | 5,651,000,000 | 4,878,000,000 | 6,337,000,000 | 5,007,000,000 | 5,153,000,000 | 4,156,000,000 | 4,251,000,000 | 4,375,000,000 | 4,066,000,000 | 3,887,000,000 | 1,994,907,000 | 2,203,977,000 |
benefits and expenses | ||||||||||||||||
claims and other policy benefits | 4,356,000,000 | 4,045,000,000 | 3,822,000,000 | 3,943,000,000 | 4,116,000,000 | 3,712,000,000 | 5,132,000,000 | 3,837,000,000 | 3,959,000,000 | 3,013,000,000 | 3,063,000,000 | 3,191,000,000 | 2,815,000,000 | 2,815,000,000 | 1,514,765,000 | 1,520,013,000 |
future policy benefits remeasurement (gains) losses | 85,000,000 | 68,000,000 | -56,000,000 | -69,000,000 | 151,000,000 | -90,000,000 | -24,000,000 | 33,000,000 | -82,000,000 | 13,000,000 | -26,000,000 | |||||
market risk benefits remeasurement (gains) losses | -1,000,000 | -17,000,000 | 29,000,000 | -32,000,000 | 31,000,000 | -8,000,000 | -35,000,000 | 28,000,000 | -21,000,000 | -31,000,000 | 14,000,000 | |||||
interest credited | 547,000,000 | 314,000,000 | 299,000,000 | 292,000,000 | 310,000,000 | 231,000,000 | 254,000,000 | 217,000,000 | 223,000,000 | 209,000,000 | 215,000,000 | 214,000,000 | 189,000,000 | 138,000,000 | 35,251,000 | 96,196,000 |
policy acquisition costs and other insurance expenses | 471,000,000 | 433,000,000 | 417,000,000 | 411,000,000 | 452,000,000 | 391,000,000 | 387,000,000 | 369,000,000 | 348,000,000 | 349,000,000 | 331,000,000 | 355,000,000 | 396,000,000 | 393,000,000 | 149,228,000 | 261,282,000 |
other operating expenses | 328,000,000 | 325,000,000 | 300,000,000 | 385,000,000 | 299,000,000 | 301,000,000 | 283,000,000 | 290,000,000 | 274,000,000 | 275,000,000 | 250,000,000 | 289,000,000 | 251,000,000 | 243,000,000 | 94,029,000 | 97,161,000 |
interest expense | 98,000,000 | 90,000,000 | 80,000,000 | 86,000,000 | 78,000,000 | 72,000,000 | 68,000,000 | 69,000,000 | 72,000,000 | 63,000,000 | 50,000,000 | 54,000,000 | 46,000,000 | 42,000,000 | 27,025,000 | 25,818,000 |
total benefits and expenses | 5,884,000,000 | 5,258,000,000 | 4,891,000,000 | 5,016,000,000 | 5,437,000,000 | 4,609,000,000 | 6,065,000,000 | 4,843,000,000 | 4,773,000,000 | 3,891,000,000 | 3,900,000,000 | 4,104,000,000 | 3,700,000,000 | 3,633,000,000 | 1,823,367,000 | 2,003,571,000 |
income before income taxes | 320,000,000 | 341,000,000 | 369,000,000 | 225,000,000 | 214,000,000 | 269,000,000 | 272,000,000 | 164,000,000 | 380,000,000 | 265,000,000 | 351,000,000 | 271,000,000 | 366,000,000 | 254,000,000 | 171,540,000 | 200,406,000 |
benefit from income taxes | 65,000,000 | 160,000,000 | 81,000,000 | 75,000,000 | 56,000,000 | 65,000,000 | 60,000,000 | 4,000,000 | 91,000,000 | 58,000,000 | 98,000,000 | 65,000,000 | 81,000,000 | 55,000,000 | 24,155,000 | 67,518,000 |
net income | 255,000,000 | 181,000,000 | 288,000,000 | 150,000,000 | 158,000,000 | 204,000,000 | 212,000,000 | 160,000,000 | 289,000,000 | 207,000,000 | 253,000,000 | 206,000,000 | 285,000,000 | 199,000,000 | 147,385,000 | 132,888,000 |
yoy | 61.39% | -11.27% | 35.85% | -6.25% | -45.33% | -1.45% | -16.21% | -22.33% | 1.40% | 4.02% | 71.66% | 55.02% | ||||
qoq | 40.88% | -37.15% | 92.00% | -5.06% | -22.55% | -3.77% | 32.50% | -44.64% | 39.61% | -18.18% | 22.82% | -27.72% | 43.22% | 35.02% | 10.91% | |
net income margin % | ||||||||||||||||
net income attributable to noncontrolling interest | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | ||
net income available to rga, inc. shareholders | 253,000,000 | 180,000,000 | 286,000,000 | 148,000,000 | 156,000,000 | 203,000,000 | 210,000,000 | 158,000,000 | 287,000,000 | 205,000,000 | 252,000,000 | 204,000,000 | 284,000,000 | 198,000,000 | ||
earnings per share | ||||||||||||||||
basic earnings per share | 3.85 | 2.72 | 4.33 | 2.26 | 2.37 | 3.07 | 3.2 | 2.41 | 4.34 | 3.09 | 3.77 | 3.06 | 4.24 | 2.95 | 2 | 1.8 |
diluted earnings per share | 3.81 | 2.7 | 4.27 | 2.2 | 2.33 | 3.03 | 3.16 | 2.38 | 4.29 | 3.05 | 3.72 | 3.02 | 4.19 | 2.92 | 1.98 | 1.78 |
collateral finance and securitization expense | 3,000,000 | 1,000,000 | 3,000,000 | 2,000,000 | ||||||||||||
revenues: | ||||||||||||||||
benefits and expenses: | ||||||||||||||||
earnings per share: | ||||||||||||||||
investment income, net of related expenses | 268,210,000 | 337,436,000 | ||||||||||||||
investment related gains, net: | ||||||||||||||||
other-than-temporary impairments on fixed maturity securities | -11,911,000 | -5,582,000 | ||||||||||||||
other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income | 3,089,000 | 292,000 | ||||||||||||||
other investment related gains | -130,778,000 | 32,678,000 | ||||||||||||||
total investment related gains | -139,600,000 | 27,388,000 | ||||||||||||||
collateral finance facility expense | 3,069,000 | 3,101,000 | ||||||||||||||
dividends declared per share | 0.18 | 0.12 | ||||||||||||||
cash flows from operating activities: | ||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
change in operating assets and liabilities: | ||||||||||||||||
accrued investment income | -64,464 | -31,378 | ||||||||||||||
premiums receivable and other reinsurance balances | -86,339 | 66,922 | ||||||||||||||
deferred policy acquisition costs | -104,267 | 33,008 | ||||||||||||||
reinsurance ceded receivable balances | 42,409 | -11,307 | ||||||||||||||
future policy benefits, other policy claims and benefits, and other reinsurance balances | 669,174 | 332,611 | ||||||||||||||
deferred income taxes | 68,059 | -34,698 | ||||||||||||||
other assets and other liabilities | -46,320 | 41,262 | ||||||||||||||
amortization of net investment premiums, discounts and other | -100,328 | -67,755 | ||||||||||||||
gain on repurchase of collateral finance facility securities | -55,840 | |||||||||||||||
excess tax benefits from share-based payment arrangement | -4,418 | -2,690 | ||||||||||||||
other | 86,630 | 69,143 | ||||||||||||||
net cash from operating activities | 833,977 | 537,814 | ||||||||||||||
cash flows from investing activities: | ||||||||||||||||
sales of fixed maturity securities available-for-sale | 2,338,405 | 1,791,826 | ||||||||||||||
maturities of fixed maturity securities available-for-sale | 195,582 | 164,043 | ||||||||||||||
purchases of fixed maturity securities available-for-sale | -3,104,714 | -2,341,291 | ||||||||||||||
cash invested in mortgage loans | -117,697 | -44,679 | ||||||||||||||
cash invested in policy loans | -8,928 | -8,928 | ||||||||||||||
cash invested in funds withheld at interest | -23,784 | -10,563 | ||||||||||||||
principal payments on mortgage loans on real estate | 60,764 | 19,283 | ||||||||||||||
principal payments on policy loans | 8,456 | 7,683 | ||||||||||||||
change in short-term investments and other invested assets | -86,895 | -74,600 | ||||||||||||||
net cash from investing activities | -738,811 | -497,226 | ||||||||||||||
cash flows from financing activities: | ||||||||||||||||
dividends to stockholders | -31,039 | -17,703 | ||||||||||||||
repurchase of collateral finance facility securities | -111,831 | -7,586 | ||||||||||||||
net proceeds from long-term debt issuance | 394,388 | 394,410 | ||||||||||||||
proceeds from redemption and remarketing of trust preferred securities | 154,588 | 154,588 | ||||||||||||||
maturity of trust preferred securities | -159,473 | -159,455 | ||||||||||||||
purchases of treasury stock | -380,345 | -340,220 | ||||||||||||||
exercise of stock options | 8,680 | 15,605 | ||||||||||||||
change in cash collateral for derivative positions | 163,250 | 8,010 | ||||||||||||||
deposits on universal life and other investment type policies and contracts | 328,903 | 288,424 | ||||||||||||||
withdrawals on universal life and other investment type policies and contracts | -119,180 | -147,774 | ||||||||||||||
net cash from financing activities | 252,359 | 190,989 | ||||||||||||||
effect of exchange rate changes on cash | -8,535 | 15,735 | ||||||||||||||
change in cash and cash equivalents | 338,990 | 247,312 | ||||||||||||||
cash and cash equivalents, beginning of period | 463,661 | 463,661 | ||||||||||||||
cash and cash equivalents, end of period | 802,651 | 710,973 | ||||||||||||||
supplementary information: | ||||||||||||||||
cash paid for interest | 57,821 | 47,054 | ||||||||||||||
cash paid for income taxes, net of refunds | 110,075 | 105,107 | ||||||||||||||
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.